Intech Investment Management LLC Coherus Bio Sciences, Inc. Transaction History
Intech Investment Management LLC
- $10.8 Billion
- Q3 2025
A detailed history of Intech Investment Management LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 48,061 shares of CHRS stock, worth $57,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,061
Previous 50,077
4.03%
Holding current value
$57,192
Previous $36,000
116.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CHRS
# of Institutions
126Shares Held
54.7MCall Options Held
291KPut Options Held
120K-
Black Rock Inc. New York, NY11.8MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$12.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$6.07 Million0.38% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$3.61 Million0.2% of portfolio
-
Geode Capital Management, LLC Boston, MA2.74MShares$3.26 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $92.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...